Best in the world — 90% of Israelis over 50 are fully vaccinated against COVID. How did Israel do it?

Credit: Jack Guez/AFP
Credit: Jack Guez/AFP

A rush of Israeli medical research — some emerging too fast for academic journals to keep up — reveals that the Pfizer-BioNTech vaccine is even more effective than hoped at preventing serious disease and death, safe for nearly all adults, and almost completely free of serious side effects.

Israel’s scientific results have allowed health officials to open the inoculation program to pregnant women and nursing mothers, while the findings also showed that it was safe for those with food allergies and autoimmune diseases.

And the vaccine has proved so good at protecting the elderly, who are especially vulnerable, that hospital administrators here say it has all but eliminated the risk that covid-19 cases would collapse their critical care systems. Almost 90 percent of Israelis over 50 have been fully vaccinated.

Israel’s small population of about 9 million, and its universal national health system, makes it a natural vaccine lab for the world. 

ADVERTISEMENT

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

“Sometimes when you go from clinical trials to the real world, you get different results,” said Hagai Levine, an epidemiologist at Hebrew University and chairman of the Israel Association of Public Health Physicians. “What these studies are showing us is the vaccine gives very good protection against disease and mortality. That is great news for the world.”

Read the original post

Related article:  'Illusion of causality' and why we trust our own experiences more than science
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend